Conversely, untargeted Abx did not significantly change CD8+ T-cell/Treg ratio (Figure 7G) and the population of MDSC, CD8+ T-cells, and Tregs in tumor tissues (Figure 7H and S9B-D) even at a higher dose (10 mg/kg body weight). The gene discussed is CD8A; the disease is neoplasm.